Advertisement

Comparison of the Effectiveness of Percutaneous Intervention of the Left-Main Coronary Artery With Everolimus-Eluting Stents in Women -Vs- Men

      Everolimus-eluting stents are largely used for left main (LM) percutaneous coronary interventions (PCI). Long-term follow-up of patients who underwent LM PCI in a real world clinical setting, in particular women, have been scarcely reported. Consecutive patients who underwent unprotected LM PCI with EES at a single Institution from December 2006 to April 2016 were included. Main outcome assessed was the occurrence of major adverse cardiovascular events (MACE) as a composite of death, myocardial infarction or target lesion revascularization at follow-up. Overall, 589 patients (20.8% women) were included in the present analysis. Women were older, had lower body mass index and more frequently hypertensive compared with men. Main clinical presentation was stable coronary artery disease (CAD); unstable angina was more frequently observed in women compared with men, whereas ST-elevation myocardial infarction was less frequent. After 69.7 ± 28.3 months of follow-up, 47 patients overall experienced MACE (1.43 per 100*patients/year). MACE rate was higher in women compared with male patients, with a rate of 2.49 and 1.17 per 100*patients/year, respectively (p = 0.015). The difference was driven mainly by higher mortality in women (0.89 vs 0.15 per 100*patients/years, p = 0.002). At multivariable Cox regression, female gender was independently associated with an increased risk of MACE at follow-up (hazard ratio 2.21, 95% confidence interval 1.20 to 4.08, p = 0.011). In conclusion, EES can be safely and effectively adopted for LM PCI.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Neumann FJ
        • Sousa-Uva M
        • Ahlsson A
        • Alfonso F
        • Banning AP
        • Benedetto U
        • Byrne RA
        • Collet JP
        • Falk V
        • Head SJ
        • Jüni P
        • Kastrati A
        • Koller A
        • Kristensen SD
        • Niebauer J
        • Richter DJ
        • Seferovic PM
        • Sibbing D
        • Stefanini GG
        • Windecker S
        • Yadav R
        • Zembala MO
        • ESC Scientific Document Group
        2018 ESC/EACTS guidelines on myocardial revascularization.
        EuroIntervention. 2018; 14: 1435-1534
        • Stone GW
        • Sabik JF
        • Serruys PW
        • Simonton CA
        • Généreux P
        • Puskas J
        • Kandzari DE
        • Morice MC
        • Lembo N
        • Brown 3rd, WM
        • Taggart DP
        • Banning A
        • Merkely B
        • Horkay F
        • Boonstra PW
        • van Boven AJ
        • Ungi I
        • Bogáts G
        • Mansour S
        • Noiseux N
        • Sabaté M
        • Pomar J
        • Hickey M
        • Gershlick A
        • Buszman P
        • Bochenek A
        • Schampaert E
        • Pagé P
        • Dressler O
        • Kosmidou I
        • Mehran R
        • Pocock SJ
        • Kappetein AP
        • EXCEL Trial Investigators
        Everolimus-eluting stents or bypass surgery for left main coronary artery disease.
        N Engl J Med. 2016; 375: 2223-2235
        • Serruys PW
        • Cavalcante R
        • Collet C
        • Kappetein AP
        • Sabik 3rd, JF
        • Banning AP
        • Taggart DP
        • Sabaté M
        • Pomar J
        • Boonstra PW
        • Lembo NJ
        • Onuma Y
        • Simonton CA
        • Morice MC
        • McAndrew T
        • Dressler O
        • Stone GW
        Outcomes after coronary stenting or bypass surgery for men and women with unprotected left main disease: the EXCEL trial.
        JACC Cardiovasc Interv. 2018; 11: 1234-1243
        • Sotomi Y
        • Onuma Y
        • Cavalcante R
        • Ahn JM
        • Lee CW
        • van Klaveren D
        • de Winter RJ
        • Wykrzykowska JJ
        • Farooq V
        • Morice MC
        • Steyerberg EW
        • Park SJ
        • Serruys PW
        Geographical difference of the interaction of sex with treatment strategy in patients with multivessel disease and left main disease: a meta-analysis from SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery), PRECOMBAT (Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease), and BEST (Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease) Randomized Controlled Trials.
        Circ Cardiovasc Interv. 2017; 10: e005027
        • Shin ES
        • Lee CW
        • Ahn JM
        • Lee PH
        • Chang M
        • Kim MJ
        • Yoon SH
        • Park DW
        • Kang SJ
        • Lee SW
        • Kim YH
        • Park SW
        • Park SJ
        Sex differences in left main coronary artery stenting: different characteristics but similar outcomes for women compared with men.
        Int J Cardiol. 2018; 253: 50-54
        • Sheiban I
        • La Spina C
        • Cavallero E
        • Biondi-Zoccai G
        • Colombo F
        • Palmerini T
        • Marzocchi A
        • Tamburino C
        • Margheri M
        • Vecchi G
        • Sangiorgi G
        • Santarelli A
        • Bartorelli AL
        • Briguori C
        • Vignali L
        • di Pede F
        • Ramondo A
        • Fantoni C
        • de Carlo M
        • Falsini G
        • Benassi A
        • Palmieri C
        • Filippone V
        • Sangiorgi D
        • de Servi S
        Sex-related differences in patients undergoing percutaneous unprotected left main stenting.
        EuroIntervention. 2010; 5: 795-800
        • Takagi K
        • Chieffo A
        • Shannon J
        • Naganuma T
        • Tahara S
        • Fujino Y
        • Latib A
        • Montorfano M
        • Carlino M
        • Kawamoto H
        • Nakamura S
        • Colombo A
        Impact of gender on long-term mortality in patients with unprotected left main disease: the Milan and New-Tokyo (MITO) Registry.
        Cardiovasc Revasc Med. 2016; 6: 369-374
        • Chieffo A
        • Tanaka A
        • Giustino G
        • Briede I
        • Sawaya FJ
        • Daemen J
        • Kawamoto H
        • Meliga E
        • D'Ascenzo F
        • Cerrato E
        • Stefanini GG
        • Capodanno D
        • Mangiameli A
        • Templin C
        • Erglis A
        • Morice MC
        • Mehran R
        • Van Mieghem NM
        • Nakamura S
        • De Benedictis M
        • Pavani M
        • Varbella F
        • Pisaniello M
        • Sharma SK
        • Tamburino C
        • Tchetche D
        • Colombo A
        • DELTA 2 Investigators
        The DELTA 2 registry: a multicenter registry evaluating percutaneous coronary intervention with new-generation drug-eluting stents in patients with obstructive left main coronary artery disease.
        JACC Cardiovasc Interv. 2017; 10: 2401-2410
        • Barbero U
        • Kanji R
        • Cerrato E
        • Di Summa R
        • Conrotto F
        • Kawamoto H
        • Biondi-Zoccai G
        • Gili S
        • Ugo F
        • Iannaccone M
        • Gagliardi M
        • De Benedictis M
        • Doronzo B
        • Varbella F
        • D'Amico M
        • Moretti C
        • Colombo A
        • Escaned J
        • D'Ascenzo F
        Unprotected left main coronary artery disease: outcomes of treatment with second-generation drug-eluting stents—insight from the FAILS-2 study.
        J Invasive Cardiol. 2018; 30: 283-288
        • Montalescot G
        • Sechtem U
        • Achenbach S
        • Andreotti F
        • Arden C
        • Budaj A
        • Bugiardini R
        • Crea F
        • Cuisset T
        • Di Mario C
        • Ferreira JR
        • Gersh BJ
        • Gitt AK
        • Hulot JS
        • Marx N
        • Opie LH
        • Pfisterer M
        • Prescott E
        • Ruschitzka F
        • Sabaté M
        • Senior R
        • Taggart DP
        • van der Wall EE
        • Vrints CJ
        • Zamorano JL
        • Achenbach S
        • Baumgartner H
        • Bax JJ
        • Bueno H
        • Dean V
        • Deaton C
        • Erol C
        • Fagard R
        • Ferrari R
        • Hasdai D
        • Hoes AW
        • Kirchhof P
        • Knuuti J
        • Kolh P
        • Lancellotti P
        • Linhart A
        • Nihoyannopoulos P
        • Piepoli MF
        • Ponikowski P
        • Sirnes PA
        • Tamargo JL
        • Tendera M
        • Torbicki A
        • Wijns W
        • Windecker S
        • Knuuti J
        • Valgimigli M
        • Bueno H
        • Claeys MJ
        • Donner-Banzhoff N
        • Erol C
        • Frank H
        • Funck-Brentano C
        • Gaemperli O
        • Gonzalez-Juanatey JR
        • Hamilos M
        • Hasdai D
        • Husted S
        • James SK
        • Kervinen K
        • Kolh P
        • Kristensen SD
        • Lancellotti P
        • Maggioni AP
        • Piepoli MF
        • Pries AR
        • Romeo F
        • Rydén L
        • Simoons ML
        • Sirnes PA
        • Steg PG
        • Timmis A
        • Wijns W
        • Windecker S
        • Yildirir A
        • Zamorano JL
        • Task Force Members
        • ESC Committee for Practice Guidelines
        • Document Reviewers
        2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology.
        Eur Heart J. 2013; 34: 2949-3003
        • Roffi M
        • Patrono C
        • Collet JP
        • Mueller C
        • Valgimigli M
        • Andreotti F
        • Bax JJ
        • Borger MA
        • Brotons C
        • Chew DP
        • Gencer B
        • Hasenfuss G
        • Kjeldsen K
        • Lancellotti P
        • Landmesser U
        • Mehilli J
        • Mukherjee D
        • Storey RF
        • Windecker S
        • ESC Scientific Document Group
        2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).
        Eur Heart J. 2016; 37: 267-315
        • Ibanez B
        • James S
        • Agewall S
        • Antunes MJ
        • Bucciarelli-Ducci C
        • Bueno H
        • Caforio ALP
        • Crea F
        • Goudevenos JA
        • Halvorsen S
        • Hindricks G
        • Kastrati A
        • Lenzen MJ
        • Prescott E
        • Roffi M
        • Valgimigli M
        • Varenhorst C
        • Vranckx P
        • Widimský P
        • ESC Scientific Document Group
        2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).
        Eur Heart J. 2018; 39: 119-177
        • Reynolds HR
        • Hochman JS
        Cardiogenic shock: current concepts and improving outcomes.
        Circulation. 2008; 117: 686-697
        • Grossman PM
        • Gurm HS
        • McNamara R
        • Lalonde T
        • Changezi H
        • Share D
        • Smith DE
        • Chetcuti SJ
        • Moscucci M
        • Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
        Percutaneous coronary intervention complications and guide catheter size: bigger is not better.
        JACC Cardiovasc Interv. 2009; 2: 636-644
        • Buszman Pawel E.
        • Buszman Piotr P.
        • Banasiewicz-Szkróbka Iwona
        • Milewski Krzysztof P.
        • Żurakowski Aleksander
        • Orlik Bartłomiej
        • Konkolewska Magda
        • Trela Błażej
        • Janas Adam
        • Kiesz R.Stefan
        • Bochenek Andrzej
        Left main stenting in comparison with surgical revascularization: 10-year outcomes of the (Left Main Coronary Artery Stenting) LE MANS Trial.
        J Am Coll Cardiol. 2016; 9: 318-327
        • Park Duk-Woo
        • Ahn Jung-Min
        • Yun Sung-Cheol
        • Yoon Yong-Hoon
        • Kang Do-Yoon
        • Lee Pil Hyung
        • Lee Seung-Whan
        • Park Seong-Wook
        • Seung Ki Bae
        • Gwon Hyeon-Cheol
        • Jeong Myung-Ho
        • Jang Yangsoo
        • Kim Hyo-Soo
        • Seong In-Whan
        • Park Hun Sik
        • Ahn Taehoon
        • Chae In-Ho
        • Tahk Seung-Jea
        • Park Seung-Jung
        10-year outcomes of stents versus coronary artery bypass grafting for left main coronary artery disease.
        J Am Coll Cardiol. 2018; 72: 2813-2822
        • Farooq V
        • Serruys PW
        • Bourantas C
        • Vranckx P
        • Diletti R
        • Garcia Garcia HM
        • Holmes DR
        • Kappetein AP
        • Mack M
        • Feldman T
        • Morice MC
        • Colombo A
        • Morel MA
        • de Vries T
        • van Es GA
        • Steyerberg EW
        • Dawkins KD
        • Mohr FW
        • James S
        • Ståhle E
        Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial.
        Eur Heart J. 2012; 33: 3105-3113
        • Hordijk-Trion M
        • Lenzen M
        • Wijns W
        • de Jaegere P
        • Simoons ML
        • Scholte op Reimer WJ
        • Bertrand ME
        • Mercado N
        • Boersma E
        • EHS-CR Investigators
        Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization.
        Eur Heart J. 2006; 27: 671-678
        • Kennedy-Martin T
        • Curtis S
        • Faries D
        • Robinson S
        • Johnston J
        A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results.
        Trials. 2015; 16: 495
        • Jager KJ
        • Zoccali C
        • Macleod A
        • Dekker FW
        Confounding: what it is and how to deal with it.
        Kidney Int. 2008; 73: 256-260